This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Jessica Mendoza: A quick heads up before we get started. This episode ...

As part of its commitment to neuroscience and mental health treatments, Johnson & Johnson (NYSE:JNJ) is advancing psychedelic medicine with Spravato (esketamine), an FDA-approved nasal spray for ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Alkermes plc (ALKS) stands against the other psychedelic stocks.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Cybin Inc. (NYSEAMERICAN:CYBN) stands against the other ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other psychedelic ...

Spravato (esketamine) has possible interactions with alcohol, some other drugs, and certain supplements. Examples include Adderall and benzodiazepines such as clonazepam (Klonopin). Talk with your ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Medicare does not currently provide coverage for ketamine therapy or infusions to treat mental health conditions. This is because the Food and Drug Administration (FDA) only approves the drug ...